You just read:

FDA In Brief: FDA takes new steps to broaden patient participation in cancer clinical trials, advancing policies to promote inclusion of pediatric patients and patients with medical conditions that can occur alongside cancer

News provided by

U.S. Food and Drug Administration

Mar 12, 2019, 10:19 ET